Royalty Pharma Stock Options Expiring on 17th of January

RPRX Stock  USD 30.30  0.45  1.46%   

Royalty Total Stockholder Equity

Total Stockholder Equity

7.88 Billion

At this time, Royalty Pharma's Total Stockholder Equity is fairly stable compared to the past year.

Royalty Pharma Corporate Management

Eric SchneiderSenior OfficerProfile
George LloydExecutive OfficerProfile
Marshall MDExecutive InvestmentsProfile
Sandy BalkinSenior AnalyticsProfile
Sara KlymkowskySenior InvestmentsProfile
Ashwin MDExecutive InvestmentsProfile

Additional Tools for Royalty Stock Analysis

When running Royalty Pharma's price analysis, check to measure Royalty Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty Pharma is operating at the current time. Most of Royalty Pharma's value examination focuses on studying past and present price action to predict the probability of Royalty Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty Pharma's price. Additionally, you may evaluate how the addition of Royalty Pharma to your portfolios can decrease your overall portfolio volatility.